A New Class of Potential Chloroquine-Resistance Reversal Agents for Plasmodia:  Syntheses and Biological Evaluation of 1-(3‘-Diethylaminopropyl)-3-(substituted phenylmethylene)pyrrolidines

Journal of Medicinal Chemistry
2000.0

Abstract

1-(3'-Diethylaminopropyl)-3-(substituted phenylmethylene)pyrrolidines were synthesized and evaluated for CQ-resistant reversal activity. In general the compounds of the series elicit better biological response than their phenylmethyl analogues. The most active compound 4b has been evaluated in vivo in detail, and the results are presented. The possible mode of action of the compounds of this series is by inhibition of the enzyme heme oxygenase, thereby increasing the levels of heme and hemozoin, which are lethal to the parasite.

Knowledge Graph

Similar Paper

A New Class of Potential Chloroquine-Resistance Reversal Agents for Plasmodia:  Syntheses and Biological Evaluation of 1-(3‘-Diethylaminopropyl)-3-(substituted phenylmethylene)pyrrolidines
Journal of Medicinal Chemistry 2000.0
4-Aminoquinoline derived antimalarials: Synthesis, antiplasmodial activity and heme polymerization inhibition studies
European Journal of Medicinal Chemistry 2010.0
Synthesis, antimalarial activity, and cellular toxicity of new arylpyrrolylaminoquinolines
Bioorganic & Medicinal Chemistry 2010.0
2-Aminopyrimidine based 4-aminoquinoline anti-plasmodial agents. Synthesis, biological activity, structure–activity relationship and mode of action studies
European Journal of Medicinal Chemistry 2012.0
A Chloroquine-like Molecule Designed to Reverse Resistance in Plasmodium falciparum
Journal of Medicinal Chemistry 2006.0
A series of structurally simple chloroquine chemosensitizing dibemethin derivatives that inhibit chloroquine transport by PfCRT
European Journal of Medicinal Chemistry 2011.0
Synthesis and Effects on Chloroquine Susceptibility in Plasmodium falciparum of a Series of New Dihydroanthracene Derivatives
Journal of Medicinal Chemistry 2002.0
Synthesis and in Vitro and in Vivo Antimalarial Activity of N-(7-Chloro-4-quinolyl)-1,4-bis(3-aminopropyl)piperazine Derivatives
Journal of Medicinal Chemistry 2003.0
N10,N11-di-alkylamine indolo[3,2-b]quinolines as hemozoin inhibitors: Design, synthesis and antiplasmodial activity
Bioorganic & Medicinal Chemistry 2015.0
Pentacycloundecylamines and conjugates thereof as chemosensitizers and reversed chloroquine agents
Bioorganic & Medicinal Chemistry Letters 2014.0